Method of purifying tumor cells using shear stress

Patent metadata

Field	Value
Publication number	US-11921020-B2
Application number	US-202016939868-A
Country	US
Kind code	B2
Filing date	Jul 27, 2020
Priority date	Mar 24, 2011
Publication date	Mar 5, 2024
Grant date	Mar 5, 2024

Abstract

Methods for isolating viable cancer cells from a sample that comprises a mixture of cancerous cells and normal (non-cancerous) cells are provided. In the methods, a fluid preparation comprising a mixture of cancerous and normal cells is repeatedly exposed to fluid shear stresses, whereby the repeated exposure to the fluid shear stresses preferentially imparts fluid shear stress-resistance to the cancerous cells.

First claim

What is claimed is:

1. A method for purifying viable cancerous cells in an in vitro fluid preparation comprising viable cancerous cells, viable normal cells, and extracellular calcium, the method comprising:
applying an initial pulse of fluid shear stress to the preparation, wherein the initial pulse of fluid shear stress induces a fluid shear stress resistance in the viable cancerous cells such that the magnitude of shear stress required to kill the viable cancerous cells is greater than the magnitude of shear stress required to kill the viable normal cells; and
subsequently applying one or more additional pulses of fluid shear stress to the preparation, said fluid shear stress sufficient to selectively kill the viable normal cells relative to the viable cancerous cells, whereby the ratio of viable cancerous cells to viable normal cells in the preparation is increased.

2. The method of claim 1 , wherein the preparation comprises blood and the viable cancerous cells are circulating tumor cells.

3. The method of claim 1 , wherein the preparation comprises a liquid suspension comprising suspended cancerous and normal cells biopsied from a mammalian tissue.

4. The method of claim 1 , wherein the viable cancerous cells comprise cancerous cells from a human breast.

5. The method of claim 1 , wherein the viable cancerous cells comprise cancerous cells from a human prostate.

6. The method of claim 1 , wherein the viable cancerous cells are selected from the group consisting of pancreatic cells, colon cells, ovarian cells, plasma cells, lung cells, adrenal cells, liver cells and lymphocyte cells.

7. The method of claim 1 , wherein the ratio of viable cancerous cancer to viable normal cells in the preparation is at least doubled.

8. The method of claim 1 , wherein the percent viability for the viable cancerous cells is at least 40% and the percent viability for the viable normal cells is no greater than 5% substantially immediately following the application of the initial and additional pulses of fluid shear stress, wherein percent viability is determined as the percent viability relative to a control maintained without the application of shear stresses for the duration of the pulse applications.

9. The method of claim 1 , wherein the initial and additional pulses of fluid shear stress apply a fluid shear stress in the range from about 500 dyn/cm 2 to about 6500 dyn/cm 2 .

10. The method of claim 1 , wherein the additional pulses apply a supra-physiologic level of fluid shear stress.

11. The method of claim 1 , wherein the steps of applying the initial pulse of fluid shear stress to the preparation and applying one or more additional pulses of fluid shear stress to the preparation comprise passing the preparation through a conduit at a substantially constant flow rate.

12. The method of claim 1 , wherein the initial pulse and the one or more additional pulses each have a duration of no greater than about 20 msec.

13. The method of claim 1 , wherein at least two additional pulses of fluid shear stress are applied to the preparation.

14. The method of claim 1 , further comprising separating the viable cancerous cells from the viable normal cells.

15. The method of claim 1 , wherein the viable cancerous cells are breast carcinoma cells or prostate carcinoma cells; the initial and additional pulses of fluid shear stress apply a fluid shear stress in the range from about 500 dyn/cm 2 to about 6500 dyn/cm 2 ; and the ratio of viable cancerous cancer to viable normal cells in the preparation is at least doubled.

16. Method for detecting cancerous cells in a mammalian subject, the method comprising:
obtaining a cell sample from the subject, the cell sample comprising cancerous cells and normal cells;
forming a fluid preparation comprising the cancerous cells, the normal cells and extracellular calcium,
applying an initial pulse of fluid shear stress to the preparation, wherein the initial pulse of fluid shear stress induces a fluid shear stress resistance in the cancerous cells such that the magnitude of shear stress required to kill the viable cancerous cells is greater than the magnitude of shear stress required to kill the viable normal cells;
subsequently applying one or more additional pulses of fluid shear stress to the preparation comprising the fluid shear stress-resistant viable cancerous cells, said fluid shear stress sufficient to selectively kill the viable normal cells relative to the viable cancerous cells, whereby the ratio of viable cancerous cells to viable normal cells in the preparation is increased; and
subsequently measuring the concentration of viable cancerous cells in the preparation.

17. The method of claim 16 , wherein the mammalian subject is a human.

18. A method for preparing a fluid preparation comprising circulating tumor cells for a prognostic assay, the method comprising:
obtaining a blood sample from the subject, the blood sample comprising circulating tumor cells and normal cells;
forming a fluid preparation comprising the circulating tumor cells, the normal cells and extracellular calcium,
applying an initial pulse of fluid shear stress to the fluid preparation, wherein the initial pulse of fluid shear stress induces a fluid shear stress resistance in the circulating tumor cells such that the magnitude of shear stress required to kill the viable cancerous cells is greater than the magnitude of shear stress required to kill the viable normal cells;
subsequently applying one or more additional pulses of fluid shear stress to the fluid preparation, said fluid shear stress sufficient to selectively kill the viable normal cells relative to the viable cancerous cells, whereby the ratio of circulating tumor cells to viable normal cells in the preparation is increased; and
subsequently conducting an assay on the preparation, the assay providing a cancer prognosis for the subject based on the viable cancerous cells.

19. A method for purifying viable cancerous cells in a fluid preparation comprising viable circulating tumor cells viable normal cells, and extracellular calcium, wherein the viable circulating tumor cells have an induced fluid shear stress resistance due to one or more pulses of fluid shear stress experience in vivo such that the magnitude of shear stress required to kill the viable cancerous cells is greater than the magnitude of shear stress required to kill the viable normal cells, the method comprising:
applying one or more additional pulses of fluid shear stress to the preparation comprising the fluid shear stress-resistant viable circulating tumor cells, said fluid shear stress sufficient to selectively kill the viable normal cells relative to the viable cancerous cells, whereby the ratio of viable circulating tumor cells to viable normal cells in the preparation is at least doubled.

20. The method of claim 19 , wherein the one or more additional pluses apply a supra-physiologic level of fluid shear stress.

21. The method of claim 19 , wherein the preparation comprises blood and the viable cancerous cells are circulating tumor cells.

22. The method of claim 19 , wherein the preparation comprises a liquid suspension comprising suspended cancerous and normal cells biopsied from a mammalian tissue.

23. The method of claim 19 , wherein the viable cancerous cells comprise cancerous cells from a human breast.

24. The method of claim 19 , wherein the viable cancerous cells comprise cancerous cells from a human

Assignees

• Univ Iowa Res Found

Inventors

• Henry Michael D
• Barnes J Matthew

Classifications

• G01N33/575

  for cancer · CPC title

• G01N1/40 Primary

  Concentrating samples · CPC title

• B01L3/502715

  characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces · CPC title

• B01L3/50273

  characterised by the means or forces applied to move the fluids · CPC title

• C12N5/0693

  Tumour cells; Cancer cells · CPC title